Paul_Hudson_(businessman)
Paul Hudson (born 14 October 1967)[2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.[3]
Paul Hudson | |
---|---|
Born | (1967-10-14)14 October 1967[1] |
Nationality | British |
Education | Manchester Metropolitan University |
Title | CEO, Sanofi |
Term | September 2019- |
Predecessor | Olivier Brandicourt |
Children | 3 |
Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.[1]
Hudson has been CEO of Sanofi since September 2019.[4][5][6]
Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to president, AstraZeneca United States and Executive Vice President, North America.[6][7][8]
Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[1][9]
Hudson has three children with his wife Sandra and is an "ardent Manchester United football fan".[1]
- "Paul Hudson - Sanofi". www.sanofi.com.
- "Paul Hudson - Sanofi". www.sanofi.com. Retrieved 29 January 2021.
- Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
- "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates.
- "AstraZeneca announces changes to Senior Executive Team". Fiercepharma.
- "Paul Hudson". Manchester Metropolitan University. Retrieved 24 April 2023.
Business positions | ||
---|---|---|
Preceded by | CEO of Sanofi 2019–present |
Succeeded by Incumbent |